niftify.in

niftify.in

Latest Vimta Labs News

All-In-One Vimta Labs Stock News Hub: Explore the latest Vimta Labs stock and industry news. Quickly find information on Vimta Labs stock buybacks,Vimta Labs results, Vimta Labs company analysis, Vimta Labs live prices, Vimta Labs dividends, Vimta Labs bonus share, board meetings, lifetime highs, Vimta Labs targets, lows, and growth stories with AI.

Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs 30 crore during FY 2024 and Rs 7 crore in Q1 FY 2025.
Business Standard

Business Standard

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs 30 crore during FY 2024 and Rs 7 crore in Q1 FY 2025.

Fri, Aug 30, 2024

The shares of Thyrocare Technologies Limited were trading at ₹859.30, down by ₹5.30 or 0.61 per cent on the NSE
Business Line

Business Line

Thyrocare to acquire Vimta Labs’ diagnostic business for ₹7 crore

The shares of Thyrocare Technologies Limited were trading at ₹859.30, down by ₹5.30 or 0.61 per cent on the NSE

Fri, Aug 30, 2024